Try for Free

Our 7-day trial requires no credit card and you can pick your start date!

7 Day Free Trial

Drug Modality Specific Features

Drug modality areas like ADC, Bi/Multispecfic, CAR/TCR, Oncolytic Virotherapies and more come with their own specific features and granulations. For example, 1stOncology provides great granulation specifically towards bi/multispecific drugs, like TCEs, NKCEs, ADCs, Bi/multi specific, Dual immunomodulator, Conditional drug activation, Unique Targets, Use of CDx etc.

Your Conference Year? Covered!

Executive companion reports and online tools to analyze an ever-growing number of world-leading meetings in oncology like AACR, ASCO, ASH, ESMO etc. 1stOncology is also present at several leading industry meetings including Immuno-Oncology, Biologics, Target Discovery, Diagnostics and much more.

Proven & Award-winning Solution

1stOncology was the main analysis tool behind a bone metastasis peer reviewed publication (Frontiers in Immunology (IF 7.3) and the 2023 recipient of the “Top 10 Global Pharma Analytics Provider” award.

A Top 10 Global Pharma Analytic Provider

"Our mission is to deliver a superior intelligence service to cancer drug stakeholders and to make 1stOncology the go- to solution for those who are serious about their investment in oncology"

Insights You Can Trust

Since 1999, we have been 100% dedicated and focused on oncology and for 25 years now, we have provided our world-wide client base with the scientific and business insights required for time-saving and accurate analysis of competing drug development and corporate strategies.

The 1stOncology™ Service Guarantee

Unlimited support for your research from our experienced analysts dedicated to the field of cancer drug development.